Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 12, 2022

BUY
$1.29 - $4.04 $48,124 - $150,716
37,306 New
37,306 $49,000
Q3 2021

Nov 05, 2021

SELL
$5.53 - $9.28 $144,410 - $242,337
-26,114 Closed
0 $0
Q2 2021

Aug 26, 2021

BUY
$7.84 - $12.6 $204,733 - $329,036
26,114 New
26,114 $232,000
Q1 2021

May 13, 2021

SELL
$10.54 - $19.3 $393,205 - $720,005
-37,306 Closed
0 $0
Q1 2020

May 14, 2020

BUY
$10.08 - $27.21 $376,044 - $1.02 Million
37,306 New
37,306 $580,000

Others Institutions Holding AVRO

# of Institutions
1
Shares Held
559K
Call Options Held
0
Put Options Held
0

About AVROBIO, Inc.


  • Ticker AVRO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 43,773,900
  • Description
  • AVROBIO, Inc., a clinical-stage gene therapy company, develops ex vivo lentiviral-based gene therapies to treat rare diseases following a single dose worldwide. Its gene therapies employ hematopoietic stem cells that are collected from patients and modified with a lentiviral vector to insert functional copies of the gene that is defective in the...
More about AVRO
Track This Portfolio

Track Penn Mutual Asset Management, LLC Portfolio

Follow Penn Mutual Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Penn Mutual Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Penn Mutual Asset Management, LLC with notifications on news.